A phase III study investigating ceftobiprole medocaril for the treatment of acute bacterial skin and skin structure infections (ABSSSI)

Trial Profile

A phase III study investigating ceftobiprole medocaril for the treatment of acute bacterial skin and skin structure infections (ABSSSI)

Planning
Phase of Trial: Phase III

Latest Information Update: 04 Mar 2016

At a glance

  • Drugs Ceftobiprole medocaril (Primary)
  • Indications Bacterial infections; Skin and soft tissue infections
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 04 Mar 2016 New trial record
    • 29 Feb 2016 According to a Basilea Pharmaceutica media release, the company is preparing phase 3 study protocol of this study for submission to the FDA seeking Special Protocol Assessments (SPAs).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top